The board of directors of RemeGen Co., Ltd. announced that Mr. Li Jia has tendered his resignation as the chief financial officer of the Company due to his personal career development, with effect from September 4, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
30.5 HKD | +0.83% | +10.11% | -18.56% |
Apr. 26 | RemeGen Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 04 | Remegen Gets US FDA Fast Track Designation for Primary Sjögren's Syndrome Medication | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-18.56% | 3.48B | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- 9995 Stock
- News RemeGen Co., Ltd.
- Remegen Co., Ltd. Announces Resignation of Li Jia as Chief Financial Officer